BCL2L1 and neoplasm: Importantly, treatment with RO-3306 for four weeks resulted in significant inhibition of tumor growth in the KpB OC mouse model under obese and lean conditions, with a concomitant decrease in the expression of Ki-67, VEGF, and Bcl-xL, and an increase in the expression of BiP.